As of May 27
| +2.45 / +2.29%|
The 5 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 108.00, with a high estimate of 118.00 and a low estimate of 102.00. The median estimate represents a -1.47% decrease from the last price of 109.61.
The current consensus among 6 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since May, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.